Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Calmare Therapeutics Inc (CTT) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Calmare Therapeutics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 102198.
Total stock buying since 2018: $0.
Total stock sales since 2018: $0.
Total stock option exercises since 2018: $80,000.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2018 | 0 | $0 | 0 | $0 | 5,594,117 | $80,000 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2018-02 | 0 | $0 | 0 | $0 | 5,594,117 | $80,000 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-02-12 | Mir Conrad F (President & CEO) | Option Ex | 1,000,000 | .08 | 80,000 |
2018-02-12 | Brennan Peter F | Option Ex | 4,594,117 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of CTT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Calmare Therapeutics Inc (symbol CTT, CIK number 102198) see the Securities and Exchange Commission (SEC) website.